Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 17, 2019 08:30 ET | Source: Hagens Berman Sobol Shapiro LLP

9-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching

SAN FRANCISCO, Nov. 17, 2019 (GLOBE NEWSWIRE) -- Hagens Berman urges Myriad Genetics, Inc. (NASDAQ: MYGN) investors who have suffered losses in excess of $50,000 to submit their losses now or...
November 12, 2019 20:07 ET | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching

SAN FRANCISCO, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Hagens Berman urges Myriad Genetics, Inc. (NASDAQ: MYGN) investors who have suffered losses in excess of $50,000 to submit their losses now or...
November 04, 2019 20:01 ET | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Myriad Genetics (MYGN) Investors of Securities Class Action, Encourages Investors Who Suffered Significant Losses to Contact the Firm

Class-action law firm urges MYGN investors who have suffered losses of $50K+ to submit your loss now to learn if they qualify to recover their investment losses. SAN FRANCISCO, Nov. 04, 2019 ...
October 23, 2019 20:10 ET | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, REMINDS MYGN INVESTORS OF CLASS ACTION: Myriad Genetics (MYGN) Investors Who Suffered Significant Losses are Encouraged to Contact the Firm

Class-action law firm urges MYGN investors who have suffered losses of $50K+ to submit your loss now to learn if they qualify to recover their investment losses. SAN FRANCISCO, Oct. 23, 2019 (GLOBE...
October 16, 2019 20:04 ET | Source: Hagens Berman Sobol Shapiro LLP

MYGN SHAREHOLDER REMINDER: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of Securities Fraud Lawsuit, Encourages Investors Who Lost $50,000+ to Contact the Firm

Class-action law firm urges MYGN investors who have suffered losses of $50K+ to submit your loss now to learn if they qualify to recover their investment losses. SAN FRANCISCO, Oct. 16, 2019 (GLOBE...
October 07, 2019 19:48 ET | Source: Hagens Berman Sobol Shapiro LLP

MYGN CLASS ACTION REMINDER: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of Securities Fraud Lawsuit, Encourages Investors Who Lost $50,000+ to Contact the Firm

Class-action law firm urges MYGN investors who have suffered losses of $50,000+ to learn their shareholder rights SAN FRANCISCO, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in...
October 01, 2019 20:04 ET | Source: Hagens Berman Sobol Shapiro LLP

MYGN CLASS ACTION REMINDER: Hagens Berman Reminds Investors in Myriad Genetics (MYGN) of Securities Fraud Lawsuit

SAN FRANCISCO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the pending securities class action and urges MYGN investors who have...
September 23, 2019 20:02 ET | Source: Hagens Berman Sobol Shapiro LLP

MYGN INVESTIGATION REMINDER: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of the Firm’s Ongoing Investigation of Possible Disclosure Violations

SAN FRANCISCO, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the firm’s investigation of possible disclosure violations. RELEVANT...
September 17, 2019 20:06 ET | Source: Hagens Berman Sobol Shapiro LLP

MYGN Loss Alert: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of Ongoing Investigation for Possible Disclosure Violations

SAN FRANCISCO, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the firm’s investigation of possible disclosure violations. RELEVANT...
September 03, 2019 20:12 ET | Source: Hagens Berman Sobol Shapiro LLP

MYGN INVESTIGATION REMINDER: Hagens Berman Investigating Myriad Genetics (MYGN) For Possible Disclosure Violations

SAN FRANCISCO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the firm’s investigation of possible disclosure violations concerning its...

Next Page keyboard_arrow_right